EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of Prednisolone on Clinical and Cytokine mRNA Profiling in Complex Regional Pain Syndrome

Jayantee Kalita, Ruchi Shukla, Prakash C Pandey

Journal of Molecular Neuroscience · 2024

DOI: 10.1007/s12031-024-02290-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Molecular Neuroscience, 2024. Verfasst von Jayantee Kalita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India. jayanteek@…. Hauptthemen laut MEDLINE: Prednisolone, RNA, Messenger. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cardinal clinical features of complex regional pain syndrome type I (CRPS-I) are pain, edema, autonomic changes, and limitation of motoric movement, which may indicate the role of inflammation and cytokines. We report the effect of prednisolone on the clinical severity and mRNA profiling of proinflammatory (tumor necrosis factor (TNF)-α and interleukin (IL)-2) and anti-inflammatory cytokines (IL-10 and transforming growth factor (TGF)-β) in the patient with CRPS-I. Thirty-nine patients with CRPS-I of shoulder joint were enrolled. Their CRPS, Visual Analog Scale (VAS) and Daily Sleep Interference Scale (DSIS) scores were recorded. TNF-α, IL-2, IL-10, and TGF-β gene expressions at mRNA of whole blood were measured by reverse transcriptase polymerase chain reaction. Patients were randomized to prednisolone 20 mg or 40 mg using 1: 1 randomization. The primary outcome was change in VAS score, and secondary outcomes were change in CRPS and DSIS scores at 1 month. Side effects were noted. The patients had increased expressions of TNF-α (p < 0.001) and IL-2 (p < 0.001) and reduced IL-10 (p < 0.01) mRNA compared to the healthy controls. The baseline characteristics were matched between the two treatment arms. At 1 month, CRPS, VAS, and DSIS scores improved significantly compared to baseline, which paralleled with improvement in IL-10 (p < 0.032) and reduction in TNF-α (p = 0.046). The improvement in clinical and biomarkers was similar in prednisolone 20 mg and 40 mg arms. None had to be withdrawn due to severe side effects. Future study in larger cohort may validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrednisoloneRNA, MessengerHumansMaleFemaleAdultMiddle AgedAnti-Inflammatory AgentsTumor Necrosis Factor-alphaInterleukin-10CytokinesInterleukin-2Reflex Sympathetic DystrophyComplex Regional Pain Syndromes

Stichwörter der Autor:innen

Complex regional pain syndromeCorticosteroidCytokineInterleukinTumor necrosis factor

Substanzen

PrednisoloneRNA, MessengerAnti-Inflammatory AgentsTumor Necrosis Factor-alphaInterleukin-10CytokinesInterleukin-2

Autor:innen und Institutionen

  • Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India. jayanteek@yahoo.com.
  • Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India.

Zitieren

APA

Kalita, J., Shukla, R., & Pandey, P. C. (2024). Effect of Prednisolone on Clinical and Cytokine mRNA Profiling in Complex Regional Pain Syndrome. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-024-02290-8

Vancouver

Kalita J, Shukla R, Pandey PC. Effect of Prednisolone on Clinical and Cytokine mRNA Profiling in Complex Regional Pain Syndrome. Journal of Molecular Neuroscience. 2024. doi:10.1007/s12031-024-02290-8

BibTeX
@article{Kalita2024,
  author = {Kalita, Jayantee and Shukla, Ruchi and Pandey, Prakash C},
  title = {Effect of Prednisolone on Clinical and Cytokine mRNA Profiling in Complex Regional Pain Syndrome},
  journal = {Journal of Molecular Neuroscience},
  year = {2024},
  doi = {10.1007/s12031-024-02290-8}
}
Kostenlos starten →